Nu-Med Plus (NUMD) Other Non Operating Income (2015 - 2021)
Nu-Med Plus' (NUMD) quarterly Other Non Operating Income came in at $9384.0 in Q2 2021, up 100.14% quarter-over-quarter from -$6.7 million in Q1 2017.
Nu-Med Plus (NUMD) Other Non Operating Income (2015 - 2021) Analysis & Trends
Nu-Med Plus has disclosed Other Non Operating Income across 4 years of filings, most recently posting $9384.0 for Q2 2021.
- Other Non Operating Income for Q2 2021 came in at $9384.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $9384.0 (changed N/A YoY), and the FY2022 annual result was $50000.0, up 432.82% from the prior year.
- Other Non Operating Income came in at $9384.0 for Q2 2021 at Nu-Med Plus, up from -$6.7 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $9384.0 in Q2 2021 to a low of -$6.7 million in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 9,384.00 |
| Mar 31, 2017 | -6.72 Mn |
| Dec 31, 2016 | 10.94 Mn |
| Mar 31, 2016 | 11.05 Mn |
| Dec 31, 2015 | -7.92 Mn |